APTPUO -Winter 2025 | BPS 4102 A00 (Pharmaceuticals: Federal and International Regulations )

Posted:
7/25/2024, 5:00:00 PM

Location(s):
Ontario, Canada ⋅ Ottawa, Ontario, Canada ⋅ St. Catharines, Ontario, Canada

Experience Level(s):
Junior ⋅ Mid Level ⋅ Senior

Field(s):
Product

Location:

Main Campus

Session:

2025 Trimestre d'hiver | Winter Term

Faculty:

Faculté des sciences / Faculty of Science

Unit:

Department of Chemistry and Biomolecular Sciences_PT

Course Title:

Pharmaceuticals: Federal and International Regulations

Course Code:

BPS 4102

Section:

A00

Course Description:

Pharmaceuticals: Federal and International Regulations. Introduction to Canadian Acts, Regulations and Guidelines pertaining to registration of agents affecting humans, animals and/or the environment. Comparative information on international trends and regulations. Basic knowledge for preparing submission packages in support of registration of new biopharmaceutical products. Discussion on the submission review process undertaken by Canadian regulatory agencies in carrying out detailed risk assessment of new products. Not necessarily offered every year.

Posting limited to:

Professeur à temps-partiel régulier / Regular Part-Time Professor

Date Posted:

July 26, 2024

Closing Date:

Note: Applications will be accepted until 11:59 PM on the day prior to the Posting End Date above

Expected Enrolment:

200

Approval date:

July 26, 2024

Number of credits:

3

Work Hours:

39

Course type:

B

Posting type:

Régulier / Regular

Language of instruction:

Anglais | English

Competence in second language:

Passive

Course Schedule:

Lundi | Monday 19:00-22:00 - -

Requirements:

Doctorate in science with a specialization relevant to Pharmaceutical Science. Experience with and a working knowledge of federal pharmaceutical regulation. The ideal candidate would have post-doctoral training in the field of biotherapeutic research and development. Former teaching experience related to pharmaceuticals is an asset. An ability to coordinate guest lectures with subject matter experts in the topics to be covered by the course is required.

*The provisions of Article 5.1.2 will apply. 
https://hrdocrh.uottawa.ca/info/en-ca/aptpuo/policies.html

Additional Information and/or Comments:

An acceptable level of education and/or experience could be viewed as being equivalent to the educational required and/or demonstrated experience. If you are invited to continue the selection process, please notify us of any adaptive measures you might require. Information you send us will be handled respectfully and in complete confidence. Employees are required under provincial law to successfully complete all mandatory legislated training. The list of training may be modified by provincial law.

The hiring process will be governed by the current APTPUO collective agreements; you can click here for the main unit, here for the OLBI unit, or here for the Toronto/Windsor unit to find out more.

The University of Ottawa embraces diversity and inclusion in the workplace. We are passionate about our people and committed to employment equity. We foster a culture of respect, teamwork and inclusion, where collaboration, innovation, and creativity fuel our quest for research and teaching excellence. While all qualified persons are invited to apply, we welcome applications from qualified Indigenous persons, racialized persons, persons with disabilities, women and LGBTQIA2S+ persons. The University is committed to creating and maintaining an accessible, barrier-free work environment. The University is also committed to working with applicants with disabilities requesting accommodation during the recruitment, assessment and selection processes. Applicants with disabilities may contact [email protected] to communicate the accommodation need. All qualified candidates are encouraged to apply; however, Canadians and permanent residents will be given priority.

Prior to May 1, 2022, the University required all students, faculty, staff, and visitors (including contractors) to be fully vaccinated against Covid-19 as defined in Policy 129 – Covid-19 Vaccination. This policy was suspended effective May 1, 2022 but may be reinstated at any point in the future depending on public health guidelines and the recommendations of experts.